Literature DB >> 23898435

Outcomes of surgical management of xanthelasma palpebrarum.

Hoon Young Lee1, Ung Sik Jin, Kyung Won Minn, Young-Oh Park.   

Abstract

BACKGROUND: Xanthelasma palpebrarum (XP) is a benign disorder manifesting as yellowish cholesterol-laden plaques on the eyelids. This paper presents the outcomes in patients with XP who have undergone surgical excision as the main modality of treatment.
METHODS: A retrospective review of patients who received surgery for xanthelasma palpebrarum from March 2007 to March 2011 was conducted. Patients were classified into four grades according to the location and extent of the lesion, with grade I being the mildest and grade IV being the most diffuse. Simple excision was performed in grade I and II lesions, while local flaps and skin grafts were performed in the more advanced grades.
RESULTS: Ninety-five cases from March 2007 to March 2011 were included in this study. 66 cases (70%), were treated by simple excision. Twenty-four cases (25%) and 5 cases (5%) were treated by simple excision in combination with or without local flaps and skin grafts. In approximately 1/4 of the patients, orbicularis oris muscle involvement was observed. 4 patients (4.2%) developed scar contracture postoperatively, which required a secondary procedure. Recurrence was reported in 3 patients (3.1%). Otherwise. There were no other reports of major complications or disfigurement.
CONCLUSIONS: We found that for lesions involving the deep dermis and/or muscle, surgical excision was the most appropriate therapeutic option.

Entities:  

Keywords:  Eyelids; Foam cells; Reconstructive surgical procedures; Xanthomatosis

Year:  2013        PMID: 23898435      PMCID: PMC3723999          DOI: 10.5999/aps.2013.40.4.380

Source DB:  PubMed          Journal:  Arch Plast Surg        ISSN: 2234-6163


  15 in total

1.  Xanthelasma palpebrarum: treatment with the erbium:YAG laser.

Authors:  C Borelli; P Kaudewitz
Journal:  Lasers Surg Med       Date:  2001       Impact factor: 4.025

2.  Xanthelasma palpebrarum: treatment with the ultrapulsed CO2 laser.

Authors:  C Raulin; M P Schoenermark; S Werner; B Greve
Journal:  Lasers Surg Med       Date:  1999       Impact factor: 4.025

3.  Efficacy of trichloroacetic acid (95%) in the management of xanthelasma palpebrarum.

Authors:  P S Cannon; R Ajit; B Leatherbarrow
Journal:  Clin Exp Dermatol       Date:  2010-12       Impact factor: 3.470

4.  Treatment of xanthelasma palpebrarum by 1064-nm Q-switched Nd:YAG laser: a study of 11 cases.

Authors:  T Fusade
Journal:  Br J Dermatol       Date:  2007-10-04       Impact factor: 9.302

5.  Fractional photothermolysis: a new therapeutic modality for xanthelasma.

Authors:  Tracy M Katz; Leonard H Goldberg; Paul M Friedman
Journal:  Arch Dermatol       Date:  2009-10

6.  [The underestimated depth of tissue invasion of xanthelasma--a histological study].

Authors:  H Mittelviefhaus; C Kreusser; D Böhringer; C Auw-Hädrich
Journal:  Klin Monbl Augenheilkd       Date:  2011-01-19       Impact factor: 0.700

7.  Xanthelasma palpebrarum treatment with a 1,450-nm-diode laser.

Authors:  Eun Joo Park; Sung Hwan Youn; Eun Byul Cho; Geun Soo Lee; Seung Kyung Hann; Kwang Ho Kim; Kwang Joong Kim
Journal:  Dermatol Surg       Date:  2011-06       Impact factor: 3.398

Review 8.  The pathogenesis and clinical significance of xanthelasma palpebrarum.

Authors:  R Bergman
Journal:  J Am Acad Dermatol       Date:  1994-02       Impact factor: 11.527

9.  [Argon laser coagulation of xanthelasmas].

Authors:  C Hintschich
Journal:  Ophthalmologe       Date:  1995-12       Impact factor: 1.059

10.  Xanthelasma palpebrarum and its relation to atherosclerotic risk factors and lipoprotein (a).

Authors:  Sevil Ozdöl; Sedef Sahin; Lale Tokgözoğlu
Journal:  Int J Dermatol       Date:  2008-08       Impact factor: 2.736

View more
  6 in total

1.  Serum lipid profile and clinical characteristics of patients with xanthelasma palpebrarum.

Authors:  Hossein Kavoussi; Ali Ebrahimi; Mansour Rezaei; Mazaher Ramezani; Behnaz Najafi; Reza Kavoussi
Journal:  An Bras Dermatol       Date:  2016 Jul-Aug       Impact factor: 1.896

2.  Xanthelasma Palpebrarum: More than Meets the Eye.

Authors:  Shailesh Khode; Soon Heng Terry Tan; En-Pei Amanda Tan; Sandeep Uppal
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2018-04-07

Review 3.  Xanthelasma palpebrarum - a brief review.

Authors:  Pragya A Nair; Rochit Singhal
Journal:  Clin Cosmet Investig Dermatol       Date:  2017-12-18

Review 4.  Xanthelasma: An Update on Treatment Modalities.

Authors:  Zainab Laftah; Firas Al-Niaimi
Journal:  J Cutan Aesthet Surg       Date:  2018 Jan-Mar

5.  A Modified Surgical Method Combined with Blepharoplasty Design for Treatment of Xanthelasma Palpebrarum.

Authors:  Eun Jeong Choi; Tea Min Oh; Hyun Ho Han
Journal:  Biomed Res Int       Date:  2020-11-30       Impact factor: 3.411

6.  Clinical association between serum cholesterol level and the size of xanthelasma palpebrarum.

Authors:  Young Geun Kim; Jae Wook Oh; Keun Cheol Lee; Sung Ho Yoon
Journal:  Arch Craniofac Surg       Date:  2022-04-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.